|
ENTPD7 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.082650E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.270300E-02 |
| Normal-vs-Stage2 |
1.351560E-01 |
| Normal-vs-Stage3 |
2.673600E-01 |
| Normal-vs-Stage4 |
4.669000E-01 |
| Stage1-vs-Stage2 |
9.993400E-01 |
| Stage1-vs-Stage3 |
5.077800E-01 |
| Stage1-vs-Stage4 |
1.916430E-01 |
| Stage2-vs-Stage3 |
6.298800E-01 |
| Stage2-vs-Stage4 |
3.527800E-01 |
| Stage3-vs-Stage4 |
6.323200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.370020E-01 |
| Normal-vs-AfricanAmerican |
1.923680E-03 |
| Normal-vs-Asian |
4.064600E-01 |
| Caucasian-vs-AfricanAmerican |
2.518100E-03 |
| Caucasian-vs-Asian |
7.734300E-02 |
| AfricanAmerican-vs-Asian |
6.722200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.576200E-02 |
| Normal-vs-Female |
1.631630E-01 |
| Male-vs-Female |
6.040200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.886200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.177600E-01 |
| Normal-vs-Age(61-80Yrs) |
6.304000E-02 |
| Normal-vs-Age(81-100Yrs) |
1.439030E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.259800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.808600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.809400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.353200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.889200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.012800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.753700E-02 |
| Normal-vs-Grade 2 |
1.088170E-01 |
| Normal-vs-Grade 3 |
1.247580E-01 |
| Normal-vs-Grade 4 |
3.692600E-01 |
| Grade 1-vs-Grade 2 |
1.851950E-01 |
| Grade 1-vs-Grade 3 |
1.878850E-01 |
| Grade 1-vs-Grade 4 |
1.077630E-01 |
| Grade 2-vs-Grade 3 |
9.544200E-01 |
| Grade 2-vs-Grade 4 |
5.736800E-01 |
| Grade 3-vs-Grade 4 |
4.980800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.517800E-02 |
| Normal-vs-ccB subtype |
5.476800E-01 |
| ccA subtype-vs-ccB subtype |
8.246000E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.241800E-01 |
| Normal-vs-N1 |
2.414000E-01 |
| N0-vs-N1 |
1.595620E-01 |
|
|
